Published in Gut on May 01, 2008
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol (2011) 1.48
From fatty liver to fibrosis: a tale of "second hit". World J Gastroenterol (2013) 1.26
Fructose as a key player in the development of fatty liver disease. World J Gastroenterol (2013) 1.26
Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2010) 0.91
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol (2016) 0.90
Advances in the treatment of nonalcoholic fatty liver disease. Ther Adv Endocrinol Metab (2010) 0.86
Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives. Wien Klin Wochenschr (2015) 0.75
Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance. PLoS One (2012) 0.90
N-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct (2014) 0.83
Nutritional treatment of chronic liver failure. Hepatol Res (2008) 0.80
Subclinical thyroid disease in elderly subjects. Acta Biomed (2010) 0.76